Sign Up Today and Learn More About Transcriptic Stock
Invest in or calculate the value of your shares in Transcriptic or other pre-IPO companies through EquityZen's platform.
Transcriptic Stock
Transcriptic is a SaaS-based biotechnology company providing robotic solutions for biology labs.
About Transcriptic Stock
Founded
2012
Headquarters
Menlo Park, CA, US
Total Funding
27.8M
Industries
Software, Artificial Intelligence, Data and Analytics
Transcriptic is a new kind of scientific outsourcing provider. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Transcriptic was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. Molecular cloning is just the beginning. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.
Transcriptic Press Mentions
Stay in the know about the latest news on Transcriptic
Systems and methods for processing experimental requests at remote laboratories
patents • Oct 27, 2024
Systems and methods for performing experiments at remote laboratories
patents • Oct 27, 2024
Systems and methods for managing experimental requests at remote laboratories
patents • Oct 27, 2024
Systems and methods for processing experimental workflows at remote …
patents • Oct 27, 2024
Devices and methods for handling biological specimens
patents • Oct 27, 2024
Transcriptic Management
Leadership team at Transcriptic
Head of Scientific Operations
Yin He
Head of Sales
Ginger Cooper
Join now and verify your accreditation status to gain access to:
- Transcriptic current valuation
- Transcriptic stock price
- Available deals in Transcriptic and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Transcriptic stock?
Accredited investors can buy pre-IPO stock in companies like Transcriptic through EquityZen funds. These investments are made available by existing Transcriptic shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Transcriptic stock?
Shareholders can sell their Transcriptic stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."